Background When women require induction of labour, oxytocin is the most common agent
used, delivered by an intravenous infusion titrated to uterine contraction strength and …

Background there is a dearth of papers in midwifery journals exploring the philosophical
underpinnings of various research methods. However, explaining and justifying particular …

Optimizing outcomes for women in labor at the global level requires evidence-based
guidance of health workers to improve care through appropriate patient selection and use of …

Ziel Erstellung einer offiziellen interdisziplinären Leitlinie, publiziert und koordiniert von der
Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG), der Österreichischen …

Oxytocin is a peptide hormone that plays a key role in regulating the female reproductive
system, including during labor and lactation. It is produced primarily in the hypothalamus …

Oxytocin has been suggested as a novel therapeutic against obesity, because it induces
weight loss and improves glucose tolerance in diet-induced obese rodents. A recent clinical …

The use of exogenous oxytocin to induce or augment labor has increased in recent years.
This literature‐informed review examines the action of this medication and the potential …

OBJECTIVE: To evaluate the benefits and harms of discontinuation of oxytocin after the
active phase of labor is reached. DATA SOURCES: Electronic databases (ie, MEDLINE …

While there is not a wide range of pregnancy-specific drugs, there are some very specific
high-risk areas of obstetric care for which unique pharmacological approaches have been …

Objective: to evaluate the impact of the implementation of evidence-based practices on
normal delivery care. Method: quasi-experimental, before-and-after intervention study …